Vice President, Program Lead, Developmemt Programs
CurrentVice President, Hypertension Program Leader, responsible for establishing the long-term vision, setting strategy, and achieving strong execution of the Hypertension (ALN-AGT) Development Program in order to maximize its future clinical and commercial success in the treatment of hypertension. The hypertension program (ALN-AGT) is currently in Phase 2 and as.